# Title

 Food and Drugs. PART 1270â€”HUMAN TISSUE INTENDED FOR TRANSPLANTATION


# ID

 CFR-2018-title21-vol8.Pt. 1270


# Structured Analysis Summary

| Type        | Values                                                                                 |
|:------------|:---------------------------------------------------------------------------------------|
| Constraints | ['before', 'within', 'more than', 'after', 'at least', 'prior to']                     |
| Duration    | ['12.0 year', '48.0 hour', '1.0 hour', '10.0 year']                                    |
| Condition   | ['until', 'where', 'if', 'when', 'unless']                                             |
| Entities    | ['Scope', 'English', 'Food', 'Corneal', 'Quarantine', 'Human', 'Retention', 'Written'] |
| Date        | ['2005-05-25']                                                                         |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                 |
|:--------------|:------------------------------------------------------------------------------------------------------------------------|
| within        | receive and store human tissue only for transplantation within  the same facility.                                      |
| before        | tissue derived from a human body and recovered before May 25, 2005, which: (1) Is intended for                          |
| after         | blood vessels which are intended to carry blood after  transplantation.                                                 |
| more than     | or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, |
| within        | reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of                         |
| more than     | or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, |
| within        | reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of                         |
| prior to      | crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the             |
| prior to      | crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the             |
| prior to      | evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor         |
| at least      | organization, provided the procedures are consistent with and at least  as stringent as the requirements of this part.  |
| prior to      | (c) All human tissue processed or shipped  prior to determination of donor suitability must be under quarantine,        |
| at least      | (h) Records shall be retained  at least 10 years beyond the date of transplantation if                                  |
| within        | that the human tissue be recalled and/or destroyed within 5 working days from the date of receipt                       |
| after         | the supervision of an authorized official of FDA. after                                                                 |
| within        | for retention, recall, and/or destruction of tissue (or within 5 working days of the agency's possession of             |
| within        | for retention, recall, and/or destruction of tissue (or within 5 working days of the agency's possession of             |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 48.0 hour  | (h) Human tissue shall be determined to be not suitable for transplantation if from:                                                                                                                                                                                                                                                                                                                                      |
|            |               (1) A donor whose specimen has tested repeatedly reactive on a screening test for HIV, hepatitis B, or hepatitis C;                                                                                                                                                                                                                                                                                         |
|            |               (2) A donor where blood loss is known or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the tissue donor for testing, unless: |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
|            |               (ii) An algorithm is utilized that evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor to ensure that there has not been plasma dilution sufficient to affect test results; or                                                                                                                                                                  |
|            |               (3) A donor who is 12 years of age or less and has been transfused or infused at all, unless:                                                                                                                                                                                                                                                                                                               |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
| 1.0 hour   | (h) Human tissue shall be determined to be not suitable for transplantation if from:                                                                                                                                                                                                                                                                                                                                      |
|            |               (1) A donor whose specimen has tested repeatedly reactive on a screening test for HIV, hepatitis B, or hepatitis C;                                                                                                                                                                                                                                                                                         |
|            |               (2) A donor where blood loss is known or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the tissue donor for testing, unless: |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
|            |               (ii) An algorithm is utilized that evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor to ensure that there has not been plasma dilution sufficient to affect test results; or                                                                                                                                                                  |
|            |               (3) A donor who is 12 years of age or less and has been transfused or infused at all, unless:                                                                                                                                                                                                                                                                                                               |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
| 48.0 hour  | (h) Human tissue shall be determined to be not suitable for transplantation if from:                                                                                                                                                                                                                                                                                                                                      |
|            |               (1) A donor whose specimen has tested repeatedly reactive on a screening test for HIV, hepatitis B, or hepatitis C;                                                                                                                                                                                                                                                                                         |
|            |               (2) A donor where blood loss is known or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the tissue donor for testing, unless: |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
|            |               (ii) An algorithm is utilized that evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor to ensure that there has not been plasma dilution sufficient to affect test results; or                                                                                                                                                                  |
|            |               (3) A donor who is 12 years of age or less and has been transfused or infused at all, unless:                                                                                                                                                                                                                                                                                                               |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
| 12.0 year  | (h) Human tissue shall be determined to be not suitable for transplantation if from:                                                                                                                                                                                                                                                                                                                                      |
|            |               (1) A donor whose specimen has tested repeatedly reactive on a screening test for HIV, hepatitis B, or hepatitis C;                                                                                                                                                                                                                                                                                         |
|            |               (2) A donor where blood loss is known or suspected to have occurred and transfusion/infusion of more than 2,000 milliliters (mL) of blood (i.e., whole blood, reconstituted blood, or red blood cells), or colloids within 48 hours; or more than 2,000 mL of crystalloids within 1 hour; or any combination thereof prior to the collection of a blood specimen from the tissue donor for testing, unless: |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
|            |               (ii) An algorithm is utilized that evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor to ensure that there has not been plasma dilution sufficient to affect test results; or                                                                                                                                                                  |
|            |               (3) A donor who is 12 years of age or less and has been transfused or infused at all, unless:                                                                                                                                                                                                                                                                                                               |
|            |               (i) A pretransfusion or preinfusion blood specimen from the tissue donor is available for infectious disease testing; or                                                                                                                                                                                                                                                                                    |
| 48.0 hour  | (ii) An algorithm is utilized that evaluates the volumes administered in the 48 hours prior to collecting the blood specimen from the tissue donor to ensure that there has not been plasma dilution sufficient to affect test results.                                                                                                                                                                                   |
| 10.0 year  | (h) Records shall be retained at least 10 years beyond the date of transplantation if known, distribution, disposition, or expiration, of the tissue, whichever is latest.                                                                                                                                                                                                                                                |


## Condition

| Condition   | Context                                                                                                                   |
|:------------|:--------------------------------------------------------------------------------------------------------------------------|
| if          | history and social behavior; such as the donor if living, the next of kin, the nearest available                          |
| when        | tests labeled for cadaveric specimens must be used when  available.                                                       |
| where       | (g) For corneal tissue procured under legislative consent  where a donor medical history screening interview has not      |
| if          | be determined to be not suitable for transplantation if from: (1) A donor whose specimen has tested                       |
| where       | hepatitis B, or hepatitis C; (2) A donor where blood loss is known or suspected to have                                   |
| where       | readily available to the personnel in the area where  the procedures are performed unless impractical.                    |
| unless      | in the area where the procedures are performed unless  impractical.                                                       |
| until       | (b) All human tissue shall be quarantined  until the following criteria for donor suitability are satisfied:              |
| until       | (e) Human tissue shall be quarantined  until the tissue is either determined to be suitable                               |
| if          | least 10 years beyond the date of transplantation if known, distribution, disposition, or expiration, of the tissue,      |
| if          | donor, as required by &#167;&#8201;1270.21(e) in English or, if in another language translated to English and accompanied |
| when        | her behalf in administering and enforcing this part. when                                                                 |
| until       | Human tissue offered for import must be quarantined until  the human tissue is released by FDA.                           |
| until       | the tissue that the tissue shall be retained until it is recalled by the distributor, destroyed, or                       |


## Entities

| Entities   | Context                                                                                                   |
|:-----------|:----------------------------------------------------------------------------------------------------------|
| Food       | Food  and Drugs.                                                                                          |
| Scope      | Scope .                                                                                                   |
| Quarantine | Quarantine includes the storage of such tissue in an                                                      |
| Corneal    | Corneal tissue procured under legislative consent shall be documented                                     |
| Written    | Written  procedures.                                                                                      |
| English    | of the donor, as required by &#167;&#8201;1270.21(e) in English  or, if in another language translated to |
| English    | of the donor, as required by &#167;&#8201;1270.21(e) in English  or, if in another language translated to |
| Human      | Human  tissue offered for import.                                                                         |
| Retention  | Retention , recall, and destruction of human tissue.                                                      |


## Date

| Date       | Context                                                                                                                                                       |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2005-05-25 | (j) Human tissue, for the purpose of this part means any tissue derived from a human body and recovered before May 25, 2005, which:                           |
|            |               (1) Is intended for transplantation to another human for the diagnosis, cure, mitigation, treatment, or prevention of any condition or disease; |
|            |               (2) Is recovered, processed, stored, or distributed by methods that do not change tissue function or characteristics;                           |
|            |               (3) Is not currently regulated as a human drug, biological product, or medical device;                                                          |
|            |               (4) Excludes kidney, liver, heart, lung, pancreas, or any other vascularized human organ; and                                                   |
|            |               (5) Excludes semen or other reproductive tissue, human milk, and bone marrow.                                                                   |


